This story has been updated from a previous version.

NEW YORK, June 21 – ProSanos and Management Science Associates have entered into a strategic relationship to develop and market biomedical informatics, the companies said Thursday. 

As part of the collaboration, MSA took an equity stake in ProSanos, Jonathan Morris, CEO of ProSanos, told GenomeWeb. Further financial details of the agreement were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.